NARI

Inari Medical Inc.

Price

return (12m)

p/e

-59.03

p/bv

10.67

DIVIDEND YIELD

0.00%

NARI price

Inari Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NARI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NARI

Valuation

P/E

-59.03

Sector 1.09

Industry -1.78

P/BV

10.67

Sector 1.86

Industry 1.35

P/Revenue (PSR)

8.07

Sector 1.55

Industry 2.25

EV/EBITDA

-627.84

Sector -47.62

Industry -42.38

EV/EBIT

-359.55

Sector -27.52

Industry -45.58

P/EBITDA

-133.05

Sector -32.64

Industry -23.10

P/EBIT

-87.42

Sector -43.02

Industry -27.18

P/Total Assets

6.65

Sector 0.87

Industry 0.82

P/Net Current Assets

5,119.49

Sector -27.09

Industry -72.46

P/Working Capital

40.47

Sector -4.05

Industry -2.10

EPS

-1.35

Sector -0.70

Industry -1.11

BVPS

7.50

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

86.82%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-4.70%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-8.21%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-6.92%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-13.68%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.22

Sector 0.13

Industry 0.06

Profitability

ROE

-18.07%

Sector -24.32%

Industry -33.33%

ROA

-11.27%

Sector -24.41%

Industry -45.72%

ROIC

-8.93%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.77

Sector 1.90

Industry 2.51

Net Debt / EBITDA

15.47

Sector -4.96

Industry -8.98

Net Debt / EBIT

8.86

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.26

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.62

Sector 0.46

Industry 0.52

Liabilities/Assets

0.38

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

15.71%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals NARI

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NARI Inari Medical Inc.	$0.00	-	0.00%	-59.03	10.67	-18.07%	-13.68%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.65	-8.23%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.32	-4.12%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$88.64	15.96%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.03	-1.10%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	17.37%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.59	14.02%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.54	-23.70%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.52	17.96%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NARI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Inari Medical

Inari Medical Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2020

Time since IPO - 6 years

456

Employees

Inari Medical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.64 billion, with shareholders equity totaling $434.76 million.

The company employs approximately 456 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Inari Medical Inc. reported $574.49 million in revenue, generating net income of $-78.58 million.

Key financial metrics include a P/E ratio of -59.03, a price-to-book (P/B) ratio of 10.67, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NARI.

Market cap

$4.64 billion

Net worth

$434.76 million

$434,760,000.00

Assets

$697.24 million

$697,240,000.00

Total Shares Outstanding

58.00 million

58,000,000

Average Daily Trading Volume

$2.59 million

$2,587,466.72

Sector

Health

Industry

Medical Supplies and Equipment

NARI

NARI revenue and profits

Financial Results NARI

DRAG THE FRAME TO SEE MORE DATA

NARI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35